Current Evidence for the Prevention of Endophthalmitis in Anti-VEGF Intravitreal Injections

Journal of Ophthalmology
P Et LauC J Layton

Abstract

Intravitreal injection of a therapeutic substance is the most common procedure performed in ophthalmology. It has a low incidence of serious complications but is associated with a small chance of endophthalmitis. Although the rate of endophthalmitis is between 0.019% and 0.09%, the associated visual morbidity is often devastating. Procedural changes have evolved over the years to improve patient comfort and reduce injection-related injury and infection. Despite the availability of published evidence, there remains considerable variations and lack of consensus in practical clinical settings. In addition, emerging literature concerning the use of speculums, the use of prophylactic topical antibiotics, and the setting of injections continues to impact the ophthalmologist's injection practice. This article provides an up to date assessment of various aspects of the procedure such as the setting, ventilation, type of anaesthetic, and control of sterility during the procedure; including discussions on performing bilateral eye same-day injections and the use of antibiotics.

References

Jul 2, 2002·The Journal of Hospital Infection·S Dharan, D Pittet
Dec 31, 2004·The New England Journal of Medicine·Evangelos S GragoudasUNKNOWN VEGF Inhibition Study in Ocular Neovascularization Clinical Trial Group
Feb 28, 2007·Infection Control and Hospital Epidemiology : the Official Journal of the Society of Hospital Epidemiologists of America·Manfred L RotterMichael Kundi
Apr 19, 2007·International Ophthalmology·Ammar Safar, Monica C Dellimore
May 29, 2007·Journal of Cataract and Refractive Surgery·UNKNOWN Endophthalmitis Study Group, European Society of Cataract & Refractive Surgeons
Dec 21, 2010·American Journal of Ophthalmology·Amy E Green-SimmsSophie J Bakri
Jan 31, 2012·Ophthalmic Surgery, Lasers & Imaging : the Official Journal of the International Society for Imaging in the Eye·Eleonora M LadTheodore Leng
Jun 5, 2012·Expert Opinion on Drug Delivery·Jonathan Gambrell, Shlomit Schaal
Sep 29, 2012·The British Journal of Ophthalmology·Robin G AbellBrendan J Vote
Apr 13, 2013·Middle East African Journal of Ophthalmology·Ali TabatabaiiMohammadreza Mansouri
Apr 24, 2013·Retina·Mitchell S FinemanRichard S Kaiser
Sep 26, 2013·Journal of Microbiology, Immunology, and Infection = Wei Mian Yu Gan Ran Za Zhi·Ni-Jiin ShenYee-Chun Chen
Oct 23, 2013·Ophthalmology·Philip StoreyUNKNOWN Post-Injection Endophthalmitis Study Team
May 9, 2014·Graefe's Archive for Clinical and Experimental Ophthalmology = Albrecht Von Graefes Archiv Für Klinische Und Experimentelle Ophthalmologie·Charles Q Yu, Christopher N Ta
May 13, 2014·Expert Opinion on Drug Delivery·Daniel L ChaoRaquel Goldhardt
May 28, 2014·Canadian Journal of Ophthalmology. Journal Canadien D'ophtalmologie·Lin XingJeffrey Gale
Jul 19, 2014·Ophthalmic Surgery, Lasers & Imaging Retina·Steven M CohenScott E Pautler
Feb 26, 2015·Arquivos brasileiros de oftalmologia·Gabriel Costa de Andrade, André Correa Maia de Carvalho
Mar 3, 2015·Ophthalmology·Ehsan RahimyAllen Chiang
Jun 23, 2015·Ophthalmic & Physiological Optics : the Journal of the British College of Ophthalmic Opticians (Optometrists)·Emma Samia-AlyJohn E A Somner
Nov 26, 2015·Ophthalmic Surgery, Lasers & Imaging Retina·Sunir J GargJames F Vander
Jan 14, 2016·Journal of Ophthalmic Inflammation and Infection·Mira M SachdevaAdrienne W Scott
Jan 23, 2016·The Cochrane Database of Systematic Reviews·Judith TannerMathew Fortnam
Feb 5, 2016·The New England Journal of Medicine·Methodius G TuuliGeorge A Macones
Jun 9, 2016·Acta Ophthalmologica·Andrzej Grzybowski, Piotr Brona
Aug 11, 2016·BMC Ophthalmology·Audrey Giocanti-AureganSalomon Y Cohen
Jul 21, 2015·International Journal of Retina and Vitreous·Rohan Merani, Alex P Hunyor
Feb 17, 2017·Clinical Ophthalmology·Miguel RuãoRoberto Gallego-Pinazo

❮ Previous
Next ❯

Citations

Apr 16, 2020·BMC Ophthalmology·Ruchi ShresthaSagun Narayan Joshi
Aug 4, 2019·Pharmaceutics·Christin HeneinYann Bouremel
Nov 24, 2019·Ophthalmology·Christina J FlaxelGui-Shuang Ying
Jul 27, 2021·Ophthalmic Surgery, Lasers & Imaging Retina·Samir N PatelSunir J Garg

❮ Previous
Next ❯

Related Concepts

Related Feeds

Antifungals (ASM)

An antifungal, also known as an antimycotic medication, is a pharmaceutical fungicide or fungistatic used to treat and prevent mycosis such as athlete's foot, ringworm, candidiasis, cryptococcal meningitis, and others. Discover the latest research on antifungals here.

Antifungals

An antifungal, also known as an antimycotic medication, is a pharmaceutical fungicide or fungistatic used to treat and prevent mycosis such as athlete's foot, ringworm, candidiasis, cryptococcal meningitis, and others. Discover the latest research on antifungals here.

Related Papers

Clinical & Experimental Ophthalmology
Xavier J Fagan, Salmaan Al-Qureshi
Ophthalmic Surgery, Lasers & Imaging Retina
Stephen J Kim, Howard F Fine
Asia-Pacific Journal of Ophthalmology
Timothy LaiDennis Lam
© 2022 Meta ULC. All rights reserved